HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vivo toxicological evaluation of polymeric nanocapsules after intradermal administration.

Abstract
Polymeric nanocarriers have shown great promise as delivery systems. An alternative strategy has been to explore new delivery routes, such as intradermal (i.d.), that can be used for vaccines and patch-based drug delivery. Despite their many advantages, there are few toxicity studies, especially in vivo. We report a safety assessment of biodegradable poly(ɛ-caprolactone) lipid-core nanocapsules (LNC) with a mean size of 245±10nm following single and repeated intradermal injections to Wistar rats. Suspensions were prepared by interfacial deposition of polymer. The animals (n=6/group) received a single-dose of saline solution (1.2ml/kg) or LNC (7.2×10(12)LNC/kg), or repeated-doses of two controls, saline solution or Tween 80 (0.9ml/kg), or three different concentrations of LNC (1.8, 3.6, and 5.4×10(12)LNC/kg) for 28 consecutive days. Clinical and physiological signs and mortality were observed. Samples of urine, blood, and tissue were used to perform toxicological evaluation. There were no clinical signs of toxicity or mortality, but there was a slight decrease in the relative body weights in the Tween 80-treated group (p<0.01) after repeated administration. No histopathological alterations were observed in tissues or significant changes in blood and urinary biomarkers for tissue damage. Mild alterations in white blood cells count with increases in granulocytes in the Tween-80 group (p<0.05) were found. Genotoxicity was evaluated through the comet assay, and no statistical difference was observed among the groups. Therefore, we conclude that, under the conditions of these experiments, biodegradable LNC did not present appreciable toxicity after 28 consecutive days of intradermal administration and is promising for its future application in vaccines and patch-based devices for enhancing the delivery of drugs.
AuthorsRachel P Bulcão, Fernando A de Freitas, Eliane Dallegrave, Cristina G Venturini, Marília Baierle, Juliano Durgante, Elisa Sauer, Carina Cassini, Carlos T Cerski, Paulo Zielinsky, Mirian Salvador, Adriana R Pohlmann, Sílvia S Guterres, Solange C Garcia
JournalEuropean journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V (Eur J Pharm Biopharm) Vol. 86 Issue 2 Pg. 167-77 (Feb 2014) ISSN: 1873-3441 [Electronic] Netherlands
PMID23643792 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2013 Elsevier B.V. All rights reserved.
Chemical References
  • Caproates
  • Drug Carriers
  • Lactones
  • Lipids
  • Nanocapsules
  • Polymers
  • Polysorbates
  • Suspensions
  • caprolactone
Topics
  • Animals
  • Caproates (administration & dosage, adverse effects)
  • Drug Carriers (administration & dosage, adverse effects)
  • Drug Delivery Systems (methods)
  • Granulocytes (drug effects)
  • Injections, Intradermal (methods)
  • Lactones (administration & dosage, adverse effects)
  • Lipids (administration & dosage, adverse effects)
  • Male
  • Nanocapsules (administration & dosage, adverse effects)
  • Particle Size
  • Polymers (administration & dosage, analysis)
  • Polysorbates (administration & dosage, adverse effects)
  • Rats
  • Rats, Wistar
  • Suspensions (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: